Dynamic cardiomyoplasty in the treatment of dilated cardiomyopathy: current results and perspectives.
BACKGROUND
The purpose of this article is to provide an overview of the current indications, results, and perspectives of dynamic cardiomyoplasty in the treatment of patients with dilated cardiomyopathy. Particular emphasis is placed on the clinical experience with 36 patients operated at the São Paulo Heart Institute between 1988 and 1995.


METHODS
Based on several clinical reports, the mechanisms of action of dynamic cardiomyoplasty in these patients include the enhancement of left ventricular systolic function, by the direct action of synchronized skeletal muscle flap contraction and the reversion of chamber remodeling. Moreover, both mechanisms seem to be responsible for improved diastolic function properties and for the decrease of ventricular wall stress. Besides the acceptable hospital mortality observed for patients with dilated cardiomyopathy ranging from 0% to 8% with this surgical procedure, clinical improvement after dynamic cardiomyoplasty has been demonstrated as a prevailing and significant outcome.


RESULTS
Nevertheless, the 1-year survival for these patients ranges from 82% to 86% and the 5-year survival on the order of 41% to 49%. In addition, the analysis of factors influencing the outcome showed that cardiomyoplasty long-term survival was significantly affected by the severity of preoperative clinical compromise and cardiac function impairment. On the other hand, patients with dilated cardiomyopathy who were operated in functional Class III or intermittent Class IV and with pulmonary vascular resistance below 4 Wood units, present survival rates on the order of 79% at 2 years and of 64% at 5 years of follow-up, which are similar to those reported after cardiac transplantation.


CONCLUSIONS
Furthermore, technological advances incorporated in the new cardiomyostimulators may ameliorate skeletal muscle flap performance at long term. Other developments are also discussed in this field.
Moreira
L F
LF
Heart Institute of São Paulo Unversity Medical School, Brazil.
Bocchi
E A
EA
Stolf
N A
NA
Bellotti
G
G
Jatene
A D
AD
D002311:Cardiomyopathy, Dilated / Q000401:mortality / Q000601:surgery*; D018421:Cardiomyoplasty / Q000379:methods / Q000401:mortality; D005500:Follow-Up Studies; D006801:Humans; D011788:Quality of Life; D016896:Treatment Outcome